Moderna, Inc. (NASDAQ:mRNA) is one of the Stocks Focus on Jim Cramer’s Game Plan. Cramer finished his game plan with stocks, as he commented:
Finally, on Friday we’ll hear from Moderna, one of the hottest stocks on the market this year, as people talk about their personal cancer vaccines. All I can say is that I hope they happen because you know what? We’ve been waiting for them since, well, how about since it went public seven years ago?
Photo by Ian Hutchinson on Unsplash
Moderna, Inc. (NASDAQ:MRNA) makes mRNA drugs and vaccines to protect against diseases such as the flu, COVID-19, and some other viruses. The company also works on treatments for cancer and rare diseases. During the February 2 episode, Cramer mentioned the company and highlighted it as S&P’s second-best performer in January. He stated:
Next, let’s go back to the S&P’s second-best performer in January, and that’s Moderna. That was almost 50% more, and this was… a wild ride. After practically printing money during the pandemic thanks to its COVID vaccine, Moderna plummeted 95% from its peak in 2021 to its lows last November, which really fooled a lot of people. But in recent months, the stock has found new life, nearly doubling from its lows. Now, the move began after a very positive Investor Day event in November, where Moderna said it would return to revenue growth in 2026 for the first time since 2021. Big deal.
While we recognize MRNA’s potential as an investment, we believe certain AI stocks offer greater growth potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that’s also benefiting significantly from Trump-era tariffs and the offshoring trend, check out our free report on best short-term AI stock.
READ NEXT: 30 stocks that should double in 3 years and 11 Hidden AI Stocks to Buy Right Now.
Disclosure: None. This article was originally published in Internal jumpsuit.